Article info
PDFShort report
Chronic hepatitis B reactivation following infliximab therapy in Crohn’s disease patients: need for primary prophylaxis
- Correspondence to:
Dr M Esteve
Department of Gastroenterology, Hospital Universitari Mútua de Terrassa, Plaça Dr Robert No 5, 08221 Terrassa, Barcelona, Catalonia, Spain; mestevecomastelefonica.net
Citation
Chronic hepatitis B reactivation following infliximab therapy in Crohn’s disease patients: need for primary prophylaxis
Publication history
- Accepted March 25, 2004
- Revised March 16, 2004
- First published August 11, 2004.
Online issue publication
October 26, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2004 by Gut